SenzaGen AB

Activities: Regulatory Analysis Pharmaceutical

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Research & Development

SenzaGen and MB Research Labs sign toxicology agreement

With new legislature, animal-free <em>in vitro</em> toxicological testing is a growing market in the US. This collaboration taps into this market
Analysis

Next-generation safety testing

In vitro genetic testing offers an ethical alternative to animal testing, which is also cheaper, faster and more reliable
Pharmaceutical

Swedish SenzaGen teams up with Chinese animal-free testing specialist

The partnership comes at a time when a ban on animal experiments is expected

SenzaGen strengthens its organisation with IR and communications director
Recruitment

SenzaGen recruits Business Development Director
Research & Development

Collaboration tackles respiratory irritancy hazard

SenzaGen and AstraZeneca will develop a new genomic signature to distinguish allergens from irritants in the respiratory tract
Subscribe now